Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases

Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases

US Patent 8518918 · Granted Aug 27, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antimicrobial composition2024
Pump cap for a pharmaceutical container, insert for a pump cap for a pharmaceuti2022
Antimicrobial composition2021
Methods of treating underlying inflammation from COPD or asthma2020
Methods of treating underlying inflammation from COPD or asthma2020
Methods of treating underlying inflammation from COPD or asthma2020
Combinations of flupirtine and sodium channel inhibiting substances for treating2013
Combination of anticholinergics and leukotriene receptor antagonists for the tre2012
Combination of anticholinergics and leukotriene receptor antagonists for the tre2012
Combination of anticholinergics and leukotriene receptor antagonists for the tre2012
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for t2012
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for t2012